This brand name is authorized in Lithuania, Poland
The drug EGOLANZA contains one active pharmaceutical ingredient (API):
|
1
Olanzapine dihydrochloride trihydrate
UNII N7U69T4SZR - OLANZAPINE
|
|
Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AH03 | Olanzapine | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1036290, 1036291, 1036292, 1036293, 1036294, 1056997, 1056998, 1057547, 1057548, 1057549, 1083664, 1083665, 1083666, 1083667, 1083668, 1083669, 1083670, 1083671, 1083672, 1083673 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100236900, 100239063, 100455895, 100467123 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
